Diabetes Mellitus, With Complications
6
0
0
2
Key Insights
Highlights
Success Rate
40% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
50.0%
3 terminated out of 6 trials
40.0%
-46.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation
New Concepts in Diabetic Macular Edema (DME)
Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus
Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes
Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus
Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus